Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
New macrocyclic amines showing activity as HIV entry inhibitors against wild type and multi-drug resistant viruses.
On the steps of cell-to-cell HIV transmission between CD4 T cells.
Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells.
The magnitude of interferon-gamma responses to human cytomegalovirus is predictive for HIV-1 disease progression.
Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy.
Raltegravir, an HIV-1 integrase inhibitor for HIV infection.
Drug-resistance mutations number and K70R or T215Y/F substitutions predict treatment resumption during guided treatment interruptions.
Skewed expression and up-regulation of the IL-12 and IL-18 receptors in resting and activated CD4 T cells from HIV-1-infected patients.
Viral failure in HIV-infected patients with long-lasting viral suppression who discontinued enfuvirtide.
Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen.